HCmed Innovations Co., Ltd. (TPE:6934)

Market Cap	2.39B +8.2%
Revenue (ttm)	100.23M -29.2%
Net Income	-126.11M
EPS	-3.92
Shares Out	32.72M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	284,114
Average Volume	242,836
Open	71.10
Previous Close	71.70
Day's Range	70.20 - 73.10
52-Week Range	45.45 - 175.00
Beta	n/a
RSI	30.53
Earnings Date	Apr 10, 2026

About HCmed Innovations

HCmed Innovations Co., Ltd. designs, develops, manufactures, and sells mesh nebulizers to deliver liquid medications into the respiratory airways in the United States, Europe and Asia. The company’s products include Pulmogine, a vibrating mesh nebulizer to nebulize a range of liquid medications to treat respiratory diseases and their symptoms in children and adults; and AdheResp, a breath-actuated mesh nebulizer for consumers and healthcare professionals. It also provides contract development and manufacturing organization services. The company...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2014
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6934

Financial Performance

In 2025, HCmed Innovations's revenue was 100.23 million, a decrease of -29.22% compared to the previous year's 141.61 million. Losses were -126.11 million, 61.2% more than in 2024.